Filippo Menolascina uses Co-Scientist to identify new liver disease treatments and explain why existing drugs only help certain patients.
Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at DeepMind Blog.
Stanford geneticist uses Co-Scientist to help find new treatments for chronic liver disease and liver fibrosis.
arXiv:2607. 02944v1 Announce Type: cross Abstract: We propose PRECEDE, a precedent-guided co-scientist for side-effect-aware drug redesign that revises a parent compound to mitigate a specified side effect while preserving therapeutic function.
arXiv:2609.13437v1 Announce Type: new Abstract: Scientific research is a continuous process that emphasizes inheritance. Methods developed by predecessors are often expanded upon by new researchers t...
arXiv:2502. 18864v2 Announce Type: replace Abstract: Scientific discovery is driven by scientists generating novel hypotheses for complex problems that undergo rigorous experimental validation.
Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
arXiv:2609.15938v1 Announce Type: new Abstract: Scientific agents contribute to hypothesis discovery by synthesizing evidence, assessing proposals, and developing new explanations. Recent systems com...
